135 related articles for article (PubMed ID: 24206431)
1. Therapeutic targeting of platelet-derived growth factor receptors in solid tumors.
Ehnman M; Östman A
Expert Opin Investig Drugs; 2014 Feb; 23(2):211-26. PubMed ID: 24206431
[TBL] [Abstract][Full Text] [Related]
2. Investigational platelet-derived growth factor receptor kinase inhibitors in breast cancer therapy.
Criscitiello C; Gelao L; Viale G; Esposito A; Curigliano G
Expert Opin Investig Drugs; 2014 May; 23(5):599-610. PubMed ID: 24597540
[TBL] [Abstract][Full Text] [Related]
3. Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis.
Cao Y
Trends Mol Med; 2013 Aug; 19(8):460-73. PubMed ID: 23773831
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor receptor (PDGFR): a target for anticancer therapeutics.
Board R; Jayson GC
Drug Resist Updat; 2005; 8(1-2):75-83. PubMed ID: 15939344
[TBL] [Abstract][Full Text] [Related]
5. Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor.
Rosenberg A; Mathew P
Expert Opin Investig Drugs; 2013 Jun; 22(6):787-94. PubMed ID: 23540855
[TBL] [Abstract][Full Text] [Related]
6. Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.
Arrondeau J; Huillard O; Tlemsani C; Cessot A; Boudou-Rouquette P; Blanchet B; Thomas-Schoemann A; Vidal M; Tigaud JM; Durand JP; Alexandre J; Goldwasser F
Expert Opin Investig Drugs; 2015 May; 24(5):673-87. PubMed ID: 25599887
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature.
Dai Y
Expert Opin Ther Pat; 2010 Jul; 20(7):885-97. PubMed ID: 20509775
[TBL] [Abstract][Full Text] [Related]
8. The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders.
Roskoski R
Pharmacol Res; 2018 Mar; 129():65-83. PubMed ID: 29408302
[TBL] [Abstract][Full Text] [Related]
9. PDGF receptors as targets in tumor treatment.
Ostman A; Heldin CH
Adv Cancer Res; 2007; 97():247-74. PubMed ID: 17419949
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor receptors: a therapeutic target in solid tumors.
George D
Semin Oncol; 2001 Oct; 28(5 Suppl 17):27-33. PubMed ID: 11740804
[TBL] [Abstract][Full Text] [Related]
11. Stromal expression of platelet-derived growth factor beta-receptor and platelet-derived growth factor B-chain in colorectal cancer.
Lindmark G; Sundberg C; Glimelius B; Påhlman L; Rubin K; Gerdin B
Lab Invest; 1993 Dec; 69(6):682-9. PubMed ID: 8264231
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
Erman M
J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
[TBL] [Abstract][Full Text] [Related]
13. PDGFs and their receptors.
Kazlauskas A
Gene; 2017 May; 614():1-7. PubMed ID: 28267575
[TBL] [Abstract][Full Text] [Related]
14. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma.
Ostman A
Cytokine Growth Factor Rev; 2004 Aug; 15(4):275-86. PubMed ID: 15207817
[TBL] [Abstract][Full Text] [Related]
15. New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies.
Pandey P; Khan F; Upadhyay TK; Seungjoon M; Park MN; Kim B
Biomed Pharmacother; 2023 May; 161():114491. PubMed ID: 37002577
[TBL] [Abstract][Full Text] [Related]
16. PDGF receptors in tumor biology: prognostic and predictive potential.
Paulsson J; Ehnman M; Östman A
Future Oncol; 2014; 10(9):1695-708. PubMed ID: 25145436
[TBL] [Abstract][Full Text] [Related]
17. The platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) are major players in oncogenesis, drug resistance, and attractive oncologic targets in cancer.
Wang Y; Appiah-Kubi K; Wu M; Yao X; Qian H; Wu Y; Chen Y
Growth Factors; 2016 Feb; 34(1-2):64-71. PubMed ID: 27170215
[TBL] [Abstract][Full Text] [Related]
18. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.
Bergers G; Song S; Meyer-Morse N; Bergsland E; Hanahan D
J Clin Invest; 2003 May; 111(9):1287-95. PubMed ID: 12727920
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic derivatives of platelet-derived growth factor receptors.
Jones AV; Cross NC
Cell Mol Life Sci; 2004 Dec; 61(23):2912-23. PubMed ID: 15583853
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapies in bladder cancer--an update.
Black PC; Agarwal PK; Dinney CP
Urol Oncol; 2007; 25(5):433-8. PubMed ID: 17826665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]